ANDS – Here’s an example that shows why companies should not have the CFO be the only speaker at a biotech investor conference. At the BofA presentation last week, ANDS’ CFO said, “…with RNA viruses like hepatitis B and hepatitis C…” Oops!
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”